Literature DB >> 19401913

Bromoanaindolone, a novel antimicrobial exometabolite from the cyanobacterium Anabaena constricta.

R-B Volk1, U Girreser, M Al-Refai, H Laatsch.   

Abstract

A new brominated indole alkaloid, designated as bromoanaindolone, was isolated from culture media of the cyanobacterium Anabaena constricta and was identified as 6-bromo-3-hydroxy-3-methyl-indol-2-one with a slight excess of the (3R) enantiomer. The molecular structure was elucidated on the basis of IR, MS and NMR data. This extracellular metabolite of A. constricta possessed antimicrobial (anticyanobacterial and antibacterial) activity in different test systems, such as suspension and porous matrix tests.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19401913     DOI: 10.1080/14786410802114068

Source DB:  PubMed          Journal:  Nat Prod Res        ISSN: 1478-6419            Impact factor:   2.861


  3 in total

Review 1.  Halogenated compounds from marine algae.

Authors:  Maria Teresa Cabrita; Carlos Vale; Amélia Pilar Rauter
Journal:  Mar Drugs       Date:  2010-08-09       Impact factor: 5.118

Review 2.  Extracellular Metabolites from Industrial Microalgae and Their Biotechnological Potential.

Authors:  Lu Liu; Georg Pohnert; Dong Wei
Journal:  Mar Drugs       Date:  2016-10-20       Impact factor: 5.118

3.  Microalgae show a range of responses to exometabolites of foreign species.

Authors:  Natalia G Apostolopoulou; Evangelia Smeti; Marta Lamorgese; Ioanna Varkitzi; Phillip Whitfield; Clement Regnault; Sofie Spatharis
Journal:  Algal Res       Date:  2022-03       Impact factor: 4.401

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.